Hydrogen Water Boosts Ibuprofen's Pain Relief in Chronic Inflammation

Hydrogen-Rich Water Enhances Ibuprofen-Induced Antinociception and Modulates NOX Signaling and the NLRP3 Inflammasome in Chronic Inflammatory Pain

Research hubs: Brain & Nervous System · Immune System

Authors
Giovanna Schiavoni, Weitao Wang, Sylmara Esther Negrini-Ferrari, Olga Pol
Journal
International Journal of Molecular Sciences
Year
2026
DOI
10.3390/ijms27188093
Study Type
Mouse
Outcome
Positive
Peer Reviewed
Yes
Country
Spain
Health Condition
Chronic Inflammatory Pain
Body System
Nervous System

TL;DR

Hydrogen-rich water enhanced ibuprofen's pain-relieving effects in mice with chronic inflammatory pain.

Key Finding

Combining hydrogen-rich water with a low dose of ibuprofen reduced pain responses more effectively than either treatment alone in mice with chronic inflammatory pain, alongside reductions in oxidative stress and NLRP3 inflammasome activity.

Summary

This mouse study investigated whether drinking hydrogen-rich water (water containing dissolved hydrogen gas) could boost the pain-relieving effects of ibuprofen in mice with chronic inflammatory pain. Researchers used a standard model of inflammation and tested the combination against each treatment alone. They found that combining a low dose of hydrogen-rich water with ibuprofen reduced pain sensitivity more effectively than either treatment by itself, and also reduced markers of oxidative stress (cell damage caused by unstable molecules) and inflammation in the animals' tissue and spinal cord.

Practical Takeaway

This early-stage animal study suggests that hydrogen-rich water may enhance the effectiveness of ibuprofen for inflammatory pain, potentially allowing lower drug doses — but results in mice do not always translate to humans. No human trials have tested this combination, so it is too soon to draw conclusions about whether this effect would occur in people.

Abstract (excerpt)

Chronic inflammatory pain is sustained by persistent oxidative stress and inflammatory signaling that promote peripheral and central sensitization. Although nonsteroidal anti-inflammatory drugs (NSAIDs), including ibuprofen, remain first-line therapies, their long-term use is limited…

Read the full abstract via DOI